Form 4: OptimizeRx CBO Sells Shares for Tax Obligations

OptimizeRx Chief Business Officer Andrew J. D'Silva disposed of 868 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Summary

• Andrew J. D'Silva, Chief Business Officer of OptimizeRx Corp (OPRX), reported a disposition of common stock.
• The transaction occurred on December 11, 2025.
• 868 shares of common stock were disposed of at a price of $14.03 per share.
• These shares were withheld by OptimizeRx to satisfy D'Silva's tax withholding obligations upon the vesting of restricted stock units.
• Following this transaction, D'Silva beneficially owns 45,438 shares of OptimizeRx common stock directly.

Sentiment

Score: 5

Explanation: The transaction is a routine disposition of shares to cover tax obligations upon RSU vesting, which is a neutral event for the company's operational or financial performance.

Future Outlook

NA

Industry Context

NA

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by a Chief Business Officer to cover tax obligations associated with restricted stock unit vesting. Such transactions are common and do not typically reflect a change in management's outlook or the company's fundamentals, thus not warranting a change in investment recommendation based solely on this filing.

Keywords

OptimizeRx, OPRX, Form 4, insider transaction, stock sale, tax withholding, restricted stock units, CBO, Andrew D'Silva